Creatinine-based indices may sharpen prognosis in canine pancreatitis
Bottom line
A retrospective study in Animals suggests that simple, admission-time bloodwork ratios built around creatinine may help veterinarians better identify dogs with acute pancreatitis that are at higher risk of dying during hospitalization. The study included 134 dogs with acute pancreatitis and 40 healthy controls, and evaluated the creatinine-to-albumin ratio (CAR), neutrophil–creatinine index (NCI), and neutrophil-to-lymphocyte ratio (NLR). According to the study abstract, the creatinine-derived indices outperformed NLR alone for predicting in-hospital mortality, adding to a growing body of evidence that renal dysfunction markers are closely tied to outcomes in canine acute pancreatitis. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary teams, the appeal is practicality. Creatinine, albumin, and CBC data are widely available on presentation, so composite indices based on those values could offer a low-cost way to support early triage, monitoring intensity, and conversations with pet parents about prognosis. That said, this was a retrospective study, and pancreatitis prognosis in dogs is already known to be multifactorial; prior work has linked mortality to creatinine, bilirubin, ionized calcium, SIRS, and coagulation abnormalities, while newer studies continue to test other lab-based ratios and scoring systems. (pubmed.ncbi.nlm.nih.gov)
What to watch: Whether these creatinine-derived indices are validated prospectively, compared head-to-head with established pancreatitis severity scores, and adopted as part of routine emergency and internal medicine workflows. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Study type
- Retrospective study
- Journal
- Animals
- Population
- 134 dogs with acute pancreatitis
- Control group
- 40 healthy controls
- Markers evaluated
- Creatinine-to-albumin ratio, neutrophil-creatinine index, and neutrophil-to-lymphocyte ratio
- Main finding
- Creatinine-derived indices outperformed NLR alone for predicting in-hospital mortality
- Clinical takeaway
- Admission bloodwork may help identify dogs at higher risk of dying during hospitalization
A new study in Animals points to a familiar lab value, creatinine, as the basis for potentially more useful mortality risk tools in dogs with acute pancreatitis. In a retrospective cohort of 134 affected dogs, investigators assessed the creatinine-to-albumin ratio, neutrophil–creatinine index, and neutrophil-to-lymphocyte ratio, reporting that creatinine-derived composite indices improved in-hospital mortality prediction compared with NLR alone, based on the journal abstract supplied for the paper. That finding fits with a broader trend in canine pancreatitis research: trying to extract more prognostic value from routine admission bloodwork. (pubmed.ncbi.nlm.nih.gov)
That trend has been building for years because acute pancreatitis in dogs remains common, clinically variable, and hard to stage early. Earlier work led to the Canine Acute Pancreatitis Severity, or CAPS, score, which identified systemic inflammatory response syndrome, coagulation disorders, increased creatinine, and ionized hypocalcemia as independent risk factors for short-term death. In other words, kidney-related changes were already part of the prognostic picture before this new paper, and the latest study appears to refine that signal by combining creatinine with inflammatory or protein-status markers. (pubmed.ncbi.nlm.nih.gov)
Recent literature has continued to reinforce creatinine’s importance. A 2025 retrospective study in Animals found increased serum creatinine, total bilirubin, and alkaline phosphatase at admission were associated with higher short-term mortality risk in hospitalized dogs with acute pancreatitis. Another recent study reported that low albumin and elevated creatinine-to-albumin ratios were associated with mortality in dogs more broadly, while a 2024 Veterinary Journal paper comparing neutrophil-albumin-related ratios in canine acute pancreatitis suggested some composite inflammatory-nutritional markers may outperform NLR alone, though specificity remained limited. Taken together, the field is moving toward composite markers, but the evidence is still evolving. (mdpi.com)
Direct outside commentary on this specific paper was limited in publicly indexed sources at the time of writing. Still, expert-oriented veterinary coverage has already emphasized the clinical relevance of creatinine trends in pancreatitis. Clinician’s Brief, discussing earlier prognostic work, noted that a rising creatinine value, even within the reference interval, can be a negative sign in severe illness and should be monitored closely in pancreatitis patients. That’s not an endorsement of any single ratio, but it does reflect where many clinicians are already focused: identifying subtle renal involvement early. (cliniciansbrief.com)
Why it matters: For practicing veterinarians, the biggest value here is accessibility. If CAR or NCI can reliably stratify risk using chemistry and CBC data already collected on admission, they could become practical add-ons for emergency triage, hospitalization planning, and prognosis discussions with pet parents. They may be especially useful in settings that don’t have immediate access to more specialized testing or where clinicians want another objective signal alongside ultrasound, cPL testing, physical exam findings, and established severity scores. (pubmed.ncbi.nlm.nih.gov)
But there are limits worth keeping in view. Retrospective pancreatitis studies are vulnerable to case-definition variability, referral bias, differences in treatment intensity, and confounding from concurrent disease. Composite indices can also look promising in one population and lose performance in another. That’s particularly relevant in canine acute pancreatitis, where prior studies of markers such as NLR, platelet-related ratios, RDW, bilirubin, and CRP-albumin measures have produced mixed results rather than a single clear winner. (pmc.ncbi.nlm.nih.gov)
What to watch: The next step is prospective validation, ideally with clearly defined pancreatitis criteria and direct comparison against CAPS and other emerging lab-based tools, to show whether these creatinine-derived indices actually change case management or improve outcome prediction in real-world practice. (pubmed.ncbi.nlm.nih.gov)